Goldman Sachs Alternatives takes control of Italy's Numantec in ~€700M deal
What's the deal? Goldman SachsDealroom has a profile for this one. Try Dealroom → Alternatives, the bank's private equity arm, has agreed to buy control of Italian medical equipment maker Numantec from White Bridge Investment. A person with knowledge of the matter told Reuters the sale valued Numantec at around €700 million; the companies disclosed no financial details.
What does Numantec do? Based near Mantua in northern Italy, it supplies healthcare products and drug-delivery devices. The company employs about 600 people and runs seven manufacturing facilities across Europe and the US.
What's the endgame? Under its new owners, Numantec is expected to keep expanding in Europe and building its US presence. It entered the US market last year by buying rival Health Line International.
How did we get here? White Bridge built Numantec through a string of acquisitions after a 2021 investment in Delta MedDealroom has a profile for this one. Try Dealroom →, an Italian maker of vascular access devices.
Why now? Goldman is betting on a business with steady revenues amid macroeconomic uncertainty. JPMorgan advised White Bridge, while Goldman Sachs International advised Goldman Sachs Alternatives. The transaction is expected to close in the fourth quarter.
The signal: Private equity continues to chase medtech assets prized for defensive, recurring revenues — the kind of stability investors favour when the broader economy looks shaky.
Read more: lse.co.uk
